51. Successful Delivery of RRT in Ebola Virus Disease
- Author
-
Bruce S. Ribner, Michael J. Connor, Colleen S. Kraft, G. Marshall Lyon, Jay B. Varkey, Harold A. Franch, Ian Crozier, Aneesh K. Mehta, and Ute Ströher
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,viruses ,Health Personnel ,Pilot Projects ,Disease ,medicine.disease_cause ,urologic and male genital diseases ,Real-Time Polymerase Chain Reaction ,Patient Isolation ,Health personnel ,Patient safety ,Up Front Matters ,Occupational Exposure ,Medicine ,Humans ,Renal replacement therapy ,Intensive care medicine ,Ebola virus ,business.industry ,Transmission (medicine) ,virus diseases ,General Medicine ,Acute Kidney Injury ,Hemorrhagic Fever, Ebola ,University hospital ,female genital diseases and pregnancy complications ,Clinical Practice ,Renal Replacement Therapy ,Treatment Outcome ,Nephrology ,Communicable Disease Control ,Practice Guidelines as Topic ,Patient Safety ,business - Abstract
AKI has been observed in cases of Ebola virus disease. We describe the protocol for the first known successful delivery of RRT with subsequent renal recovery in a patient with Ebola virus disease treated at Emory University Hospital, in Atlanta, Georgia. Providing RRT in Ebola virus disease is complex and requires meticulous attention to safety for the patient, healthcare workers, and the community. We specifically describe measures to decrease the risk of transmission of Ebola virus disease and report pilot data demonstrating no detectable Ebola virus genetic material in the spent RRT effluent waste. This article also proposes clinical practice guidelines for acute RRT in Ebola virus disease.
- Published
- 2014